FORWARD FEATURES CALENDAR

Intel

Partners Group acquires majority stake in €900m biotech FairJourney

Swiss private equity firm Partners Group has acquired a majority stake in FairJourney Biologics, a biotech known for its work on antibody treatments for major drugmakers such as Johnson & Johnson, in a deal that values the business at €900m, according to a report by the Financial Times.

Events

12 November, 2026 – 5:00 pm

Directory Listings